SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001127855-14-000007
Filing Date
2014-01-13
Accepted
2014-01-10 19:36:44
Documents
11
Period of Report
2013-08-31

Document Format Files

Seq Description Document Type Size
1 NAPRODIS 10K, 08.31.13 naprodis10k083113.htm 10-K 645785
2 NAPRODIS 10K, CERTIFICATION 302, CEO naprodisexh31_1.htm EX-31.1 9605
3 NAPRODIS 10K, CERTIFICATION 302, CFO naprodisexh31_2.htm EX-31.2 9615
4 NAPRODIS 10K, CERTIFICATION 906, CEO/CFO naprodisexh32_1.htm EX-32.1 4965
5 NAPRODIS 10K, GRAPHIC 1 antonchia_logo.jpg GRAPHIC 15400
  Complete submission text file 0001127855-14-000007.txt   3519200

Data Files

Seq Description Document Type Size
6 napr-20130831_cal.xml EX-101.CAL 22496
7 napr-20130831_def.xml EX-101.DEF 24606
8 napr-20130831.xml EX-101.INS 606487
9 napr-20130831_lab.xml EX-101.LAB 97636
10 napr-20130831_pre.xml EX-101.PRE 93184
11 napr-20130831.xsd EX-101.SCH 24354
Mailing Address 13250 GREGG STREET SUITE F POWAY CA 92064
Business Address 13250 GREGG STREET SUITE F POWAY CA 92064 (858) 486-8655
Naprodis, Inc. (Filer) CIK: 0001313938 (see all company filings)

IRS No.: 330903494 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 333-122009 | Film No.: 14522974
SIC: 2834 Pharmaceutical Preparations